Looking Glass: Bimanual Balanced Reaching With Visual Biofeedback



Status:Recruiting
Conditions:Healthy Studies, Neurology
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:18 - Any
Updated:10/10/2018
Start Date:August 8, 2017
End Date:November 8, 2021
Contact:Kelly Thielbar, MSOT
Email:kthielbar@sralab.org
Phone:312-238-1288

Use our guide to learn which trials are right for you!

Bimanual Balanced Reaching With Visual Biofeedback

The goal of this research study is to increase understanding of error augmentation by
applying it to visual feedback during motion tracking with a Leap Motion device - a recently
developed optical hand tracking tool - and the LookingGlass - a new, portable virtual reality
environment.

In conjunction with the Leap, large, three dimensional work spaces can provide an immersive
and virtual augmented environment for rehabilitation. Previously, experiments have utilized
the Virtual Reality Robotic and Optical Operations Machine (VRROOM) to create such visually
immersive environments. The Robotics lab as part of the Arms and Hands Lab on the 22nd floor
of the Shirley Ryan Abilitylab has developed a portable version of this system, which is more
compact and clinic-compatible. Combining this visual 3D system with the Leap creates a novel,
more capable apparatus for studying error augmentation.

This research study will have 3 different arms: 1.) a healthy group of individuals (Healthy
Arm), 2.) a group of stroke survivors within 8 months of stroke (Acute Arm), and 3.) a group
of stroke survivors that had their stroke more than 8 months ago (Chronic Arm).

Each Arm will use the Leap motion tracker and the Looking Glass to participate in a reaching
intervention. The healthy arm will only participate in 1 visit with an intervention with and
without error augmented visual feedback. The Acute Arm and the Chronic Arm will both have 2
groups: 1.) Error Augmented Visual Feedback group and 2.) Non-Augmented or Veridical Visual
Feedback group.

The Chronic Arm will have a structured intervention and evaluation protocol: Study staff will
administer outcome assessments at 3 time points: a.) prior to intervention, b.) post
intervention, and c.) 2 months after the conclusion of intervention. Intervention will occur
over the span of 6-8 weeks with the goal of 3 1-hour sessions per week.

The Acute Arm will have a less structured intervention that will occur while the participant
is an inpatient at Shirley Ryan AbilityLab. Study staff will administer outcome assessments
at at least 2 time points: a.) prior to intervention, b.) post intervention just prior to
discharge from Shirley Ryan AbilityLab. Between initial and post intervention evaluations,
midpoint evaluations will take place at a maximum of once per week if the participant's
schedule, activity tolerance, and length of stay allows. Intervention will consist of 1-hour
sessions occurring according to the availability of the participant at the rate of no more
than 2 sessions in a 24 hour period.

Investigators hope to investigate these questions:

1. Can the movement of healthy individuals be characterized with error augmented visual
feedback and veridical visual feedback?

2. Will error augmented visual feedback or veridical visual feedback result in greater
movement ability improvement?

Investigators hypothesize that in the Chronic Arm, those what trained with
error-augmented visual feedback will have improved movement ability compared to those
who trained with veridical visual feedback.

3. Is treatment with the looking glass and leap system feasible with an inpatient
population?

Investigators hypothesize that this treatment will be feasible for an inpatient population.


Inclusion Criteria:

- 8 months post stroke

- FMUE 15-50

- Active shoulder and elbow flexion-extension when supported against gravity to
accomplish a forward mediolateral and inferior-superior reaching movements of 30 cm

Exclusion Criteria:

- Bilateral paresis

- Severe sensory deficits in the affected limb

- Severe spasticity preventing movement (MAS 4 or greater at elbow)

- Aphasia, cognitive impairment or affective dysfunction that influence ability to
participate in the experiment

- Inability to provide informed consent

- Severe current medical problems

- Diffuse/multiple lesion sites or multiple strokes

- Hemi-spatial neglect or visual field cut preventing subjects from seeing the target

- Inability to maintain the testing positions

- Botox injections in the affected Upper Extremity within the past 4 months

- Concurrent participation in Upper Extremity rehab (research or prescribed therapy)

- Participation in previous, similar robotics intervention studies

- Pregnant women, children and teenagers, prisoners
We found this trial at
1
site
355 East Erie Street
Chicago, Illinois 60611
Phone: 312-238-1288
?
mi
from
Chicago, IL
Click here to add this to my saved trials